Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance-Reference-Cited by-同舟云学术

Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance

Published:2022-04-26 Issue:2 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Iovleva Alina¹^ORCID,Mustapha Mustapha M.¹,Griffith Marissa P.¹,Komarow Lauren²,Luterbach Courtney³,Evans Daniel R.¹⁴,Cober Eric⁵,Richter Sandra S.⁶,Rydell Kirsten⁷⁸,Arias Cesar A.⁷⁸,Jacob Jesse T.⁹^ORCID,Salata Robert A.¹⁰,Satlin Michael J.¹¹,Wong Darren¹²,Bonomo Robert A.¹⁰¹³¹⁴¹⁵^ORCID,van Duin David¹⁶^ORCID,Cooper Vaughn S.¹⁷^ORCID,Van Tyne Daria¹^ORCID,Doi Yohei¹¹⁸^ORCID

Affiliation:

1. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

2. The Biostatistics Center, The George Washington University, Rockville, Maryland, USA

3. Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina, Chapel Hill, North Carolina, USA

4. Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA

5. Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA

6. Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida, USA

7. Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA

8. Center for Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas USA

9. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

10. Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

11. Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA

12. Division of Infectious Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA

13. Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA

14. Departments of Biochemistry, Pharmacology, Molecular Biology and Microbiology, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USA

15. CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland, OH, USA

16. Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA

17. Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

18. Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan

Abstract

Carbapenem-resistant Acinetobacter baumannii (CR Ab ) constitutes a major threat to public health. To elucidate the molecular and clinical epidemiology of CR Ab in the United States, clinical CR Ab isolates were collected along with data on patient characteristics and outcomes, and bacterial isolates underwent whole-genome sequencing and antibiotic susceptibility phenotyping.

Funder

National Institutes of Health

NIH

US Department of Veteran Affairs

PA CURES Grant

Burroughs Wellcome Fund

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.02759-21

Reference40 articles.

1. New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections

2. Tacconelli E, Magrini N. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva, Switzerland.

3. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

4. CDC. 2019. Antibiotic resistance threats in the Unisted States. https://www.cdc.gov/drugresistance/biggest-threats.html.

5. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular epidemiology, microbiological features and infection control strategies for carbapenem-resistant Acinetobacter baumannii in a German burn and plastic surgery center (2020–2022);Antimicrobial Resistance & Infection Control;2024-09-06

2. Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019;American Journal of Infection Control;2024-09

3. Epidemiological, Phylogenetic, and Resistance Heterogeneity Among Acinetobacter baumannii in a Large U.S. Deep South Healthcare system;Open Forum Infectious Diseases;2024-08-10

4. Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence IS Aba36 in the siderophore receptor pirA;Antimicrobial Agents and Chemotherapy;2024-07-09

5. Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021–2022: identification of a novel international clone, IC11;mSphere;2024-06-25